Literature DB >> 11052224

Metabolic effects of nigrostriatal denervation in basal ganglia.

E C Hirsch1, C Périer, G Orieux, C François, J Féger, J Yelnik, M Vila, R Levy, E S Tolosa, C Marin, M Trinidad Herrero, J A Obeso, Y Agid.   

Abstract

In the past, functional changes in the circuitry of the basal ganglia that occur in Parkinson's disease were primarily analyzed with electrophysiological and 2-deoxyglucose measurements. The increased activity of the subthalamic nucleus (STN) observed has been attributed to a reduction in inhibition mediated by the external segment of the globus pallidus (GPe), secondary to the loss of dopaminergic-neuron influence on D2-receptor-bearing striato-pallidal neurons. More recently, in situ hybridization studies of cytochrome oxidase subunit I have confirmed the overactivity of the STN in the parkinsonian state. In addition, this technique has provided evidence that the change in STN activity is owing not only to decreased inhibition from the GPe but to hyperactivity of excitatory inputs from the parafascicular nucleus of the thalamus and the pedunculopontine nucleus in the brainstem.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052224     DOI: 10.1016/s1471-1931(00)00021-5

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  24 in total

1.  The primate thalamostriatal systems: Anatomical organization, functional roles and possible involvement in Parkinson's disease.

Authors:  Adriana Galvan; Yoland Smith
Journal:  Basal Ganglia       Date:  2011-11-01

2.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.

Authors:  Jose L Lanciego; Maria C Rodríguez-Oroz; Francisco J Blesa; Lydia Alvarez-Erviti; Jorge Guridi; Pedro Barroso-Chinea; Yoland Smith; Jose A Obeso
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

4.  Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Tao Xie; Liqiong Tong; Tanya Barrett; Jie Yuan; George Hatzidimitriou; Una D McCann; Kevin G Becker; David M Donovan; George A Ricaurte
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

5.  Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.

Authors:  Alireza Kashani; Catalina Betancur; Bruno Giros; Etienne Hirsch; Salah El Mestikawy
Journal:  Neurobiol Aging       Date:  2006-03-24       Impact factor: 4.673

Review 6.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

7.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

Review 8.  Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.

Authors:  Susan Duty
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

9.  Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.

Authors:  Christine Konradi; Jenny E Westin; Manolo Carta; Molly E Eaton; Katarzyna Kuter; Andrzej Dekundy; Martin Lundblad; M Angela Cenci
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

10.  High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat.

Authors:  Pascal Salin; Christine Manrique; Claude Forni; Lydia Kerkerian-Le Goff
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.